Cardiol Therapeutics Stock Forecast

Stock Price Forecast

The 2 analysts with 12-month price forecasts for Cardiol Therapeutics stock have an average target of 9.00, which predicts a 669.23% increase from the current stock price of 1.17.

Price Target: $9.00 (+669.23%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$9.00	$9.00	$9.00	$9.00
Change	+669.23%	+669.23%	+669.23%	+669.23%

* Price targets were last updated on Jun 2, 2025.

Analyst Ratings

The average analyst rating for Cardiol Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Mar '25	Apr '25	May '25	Jun '25	Jul '25	Aug '25
Strong Buy	3	3	3	3	3	2
Buy	0	0	0	0	0	0
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	3	3	3	3	3	2

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Brandon Folkes HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Initiates $9	Strong Buy	Initiates	$9	+669.23%	Jun 2, 2025
Vernon Bernardino HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $9	Strong Buy	Reiterates	$9	+669.23%	Apr 16, 2025
Vernon Bernardino HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $9	Strong Buy	Reiterates	$9	+669.23%	Apr 7, 2025
Vernon Bernardino HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $9	Strong Buy	Reiterates	$9	+669.23%	Feb 24, 2025
Vernon Bernardino HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $9	Strong Buy	Reiterates	$9	+669.23%	Dec 18, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

n/a

EPS This Year

-0.53

from -0.51

EPS Next Year

-0.77

from -0.53

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	-	78.76K	-	-	-	-	-	19.49M
Revenue Growth	-	-	-	-	-	-	-	-
EPS	-0.69	-0.73	-0.49	-0.44	-0.51	-0.53	-0.77	-0.19
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	4	4	3

Financial currency is CAD. Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027
High	n/a	n/a	33.9M
Avg	n/a	n/a	19.5M
Low	n/a	n/a	5.8M

Revenue Growth

Revenue Growth	2025	2026	2027
High	-	-	-
Avg	-	-	-
Low	-	-	-

EPS Forecast

EPS	2025	2026	2027
High	-0.48	-0.57	-0.19
Avg	-0.53	-0.77	-0.19
Low	-0.56	-0.94	-0.18

EPS Growth

EPS Growth	2025	2026	2027
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.